Associations of Hemodynamic Load and Ventricular Repolarization in Patients With Newly Diagnosed Essential Hypertension: A Long‐Term Follow‐Up Study
暂无分享,去创建一个
C. Tsioufis | C. Stefanadis | D. Tsiachris | I. Andrikou | N. Vrachnis | N. Dagres | V. Antonakis | M. Fantaki
[1] Michael Böhm,et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Journal of hypertension.
[2] R. Fogari,et al. Effects of aliskiren on QT duration and dispersion in hypertensive patients with type 2 diabetes mellitus , 2012, Diabetes, obesity & metabolism.
[3] S. Minatoguchi,et al. Effects of candesartan versus amlodipine on home-measured blood pressure, QT dispersion and left ventricular hypertrophy in high-risk hypertensive patients , 2011, Blood pressure. Supplement.
[4] A. Antonelli,et al. Effect of telmisartan on QT interval variability and autonomic control in hypertensive patients with left ventricular hypertrophy. , 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[5] P. Low,et al. Association of Increased QTc Interval With the Cardiometabolic Syndrome , 2010, Journal of clinical hypertension.
[6] Timothy Watson,et al. Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[7] Piotr Ponikowski,et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, European heart journal.
[8] William Stewart,et al. Recommendations for chamber quantification. , 2006, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[9] A. Carpi,et al. Effect of nebivolol on QT dispersion in hypertensive patients with left ventricular hypertrophy. , 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[10] M. Akbulut,et al. Effects of spironolactone and metoprolol on QT dispersion in heart failure. , 2003, Japanese heart journal.
[11] M. Nieminen,et al. Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan Intervention For Endpoint Reduction (LIFE) study. , 2003, American heart journal.
[12] M. Nieminen,et al. Relation of QT interval and QT dispersion to echocardiographic left ventricular hypertrophy and geometric pattern in hypertensive patients. The LIFE study. , 2001, Journal of hypertension.
[13] M. Malik,et al. Measurement, interpretation and clinical potential of QT dispersion. , 2000, Journal of the American College of Cardiology.
[14] C. Brilla,et al. Lisinopril-Mediated Regression of Myocardial Fibrosis in Patients With Hypertensive Heart Disease , 2000, Circulation.
[15] B V Howard,et al. Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians: The Strong Heart Study. , 2000, Circulation.
[16] T. MacDonald,et al. Irbesartan reduces QT dispersion in hypertensive individuals. , 1999, Hypertension.
[17] P. Toutouzas,et al. Regression of left ventricular hypertrophy results in improvement of QT dispersion in patients with hypertension. , 1998, American heart journal.
[18] Fraser Cummings,et al. QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin dependent diabetes: cohort study , 1998, BMJ.
[19] A. Hofman,et al. QTc dispersion predicts cardiac mortality in the elderly: the Rotterdam Study. , 1998, Circulation.
[20] J. González-Juanatey,et al. Reduction of QT and QTc dispersion during long-term treatment of systemic hypertension with enalapril. , 1998, The American journal of cardiology.
[21] P. Sever,et al. Left ventricular hypertrophy and QT dispersion in hypertension. , 1996, Hypertension.
[22] H. Huikuri,et al. Dispersion of the QT interval and autonomic modulation of heart rate in hypertensive men with and without left ventricular hypertrophy. , 1996, HYPERTENSION.
[23] A. Kadish,et al. Autonomic Effects on the QT Interval , 1996 .
[24] A. Langer,et al. Association between QT dispersion and autonomic dysfunction in patients with diabetes mellitus. , 1995, Journal of the American College of Cardiology.
[25] A. McMahon,et al. QT dispersion in essential hypertension. , 1995, QJM : monthly journal of the Association of Physicians.
[26] R. Campbell,et al. QT dispersion and components of the QT interval in ischaemia and infarction. , 1995, British heart journal.
[27] C. Lang,et al. QT dispersion and sudden unexpected death in chronic heart failure , 1994, The Lancet.
[28] N. Schiller,et al. Two-dimensional echocardiographic determination of left ventricular volume, systolic function, and mass. Summary and discussion of the 1989 recommendations of the American Society of Echocardiography. , 1991, Circulation.
[29] G. Taylor,et al. Prolonged QT interval at onset of acute myocardial infarction in predicting early phase ventricular tachycardia. , 1981, American heart journal.